| scholarly article | Q13442814 |
| P50 | author | Paolo Gresele | Q37834337 |
| P2093 | author name string | Geremia B Bolli | |
| Giovanni Davì | |||
| Emanuela Falcinelli | |||
| Giovanni Ciabattoni | |||
| Giuseppe Guglielmini | |||
| Massimiliano De Angelis | |||
| Carlo Lalli | |||
| Silvia Ciferri | |||
| Marco Ciofetta | |||
| P2860 | cites work | The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years | Q30577414 |
| Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial. | Q33491850 | ||
| Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level | Q33929071 | ||
| Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors | Q34069118 | ||
| Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview | Q34093891 | ||
| Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis | Q40837696 | ||
| Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism | Q41015991 | ||
| Platelet hyperreactivity and prognosis in survivors of myocardial infarction | Q41229453 | ||
| Diabetes and cardiovascular disease. The Framingham study | Q41509493 | ||
| In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. | Q42536696 | ||
| Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects | Q43788607 | ||
| Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial | Q44459441 | ||
| Determination of free and total insulin and C-peptide in insulin-treated diabetics | Q44647253 | ||
| Thromboxane biosynthesis and platelet function in type II diabetes mellitus | Q45056796 | ||
| Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis | Q45870786 | ||
| Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients | Q47734969 | ||
| Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. | Q50944772 | ||
| Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria | Q53998038 | ||
| Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. | Q54137065 | ||
| Effects of recent, short-term hyperglycemia on responses to hypoglycemia in humans. Relevance to the pathogenesis of hypoglycemia unawareness and hyperglycemia-induced insulin resistance. | Q54173605 | ||
| Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group | Q66972631 | ||
| Platelet abnormalities in diabetes mellitus | Q68046313 | ||
| Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus | Q68134802 | ||
| Qualitative and quantitative abnormalities of von Willebrand antigen in patients with diabetes mellitus | Q68599017 | ||
| Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program | Q68989354 | ||
| Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease | Q70255558 | ||
| A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials | Q78108659 | ||
| Are we mortgaging the medical profession? | Q95814757 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| hyperglycemia | Q271993 | ||
| P304 | page(s) | 1013-1020 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus | |
| P478 | volume | 41 |
| Q46804451 | A new case of acquired Glanzmann's thrombasthenia: diagnostic value of flow cytometry |
| Q46767665 | A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression |
| Q39654691 | A possible association between space weather conditions and the risk of acute coronary syndrome in patients with diabetes and the metabolic syndrome |
| Q35519580 | A risk score for prediction of hyperglycemia at coronary angiography |
| Q39301873 | Acute hyperglycemia and spontaneous reperfusion in acute myocardial infarction |
| Q43066959 | Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction |
| Q55287380 | Admission glycemic variability correlates with in-hospital outcomes in diabetic patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. |
| Q36102103 | Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics |
| Q37453099 | An overview of glycemic control in the coronary care unit with recommendations for clinical management |
| Q35469793 | Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty |
| Q33629000 | Barriers to Implementing an Insulin Order Form In a Non-ICU Medical Unit. |
| Q39345035 | Blood-Brain Barrier Disruption, Vascular Impairment, and Ischemia/Reperfusion Damage in Diabetic Stroke |
| Q36939649 | Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis |
| Q42016972 | Case of fulminant type 1 diabetes with coronary microcirculatory dysfunction |
| Q30429984 | Combining basal-bolus insulin infusion for tight postprandial glucose control: an in silico evaluation in adults, children, and adolescents |
| Q37713552 | Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention |
| Q46820384 | Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders |
| Q91846403 | Diabetes and Platelet Response to Low-Dose Aspirin |
| Q37167506 | Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization |
| Q83144930 | Digami too? |
| Q34541855 | Effect of abnormal fasting plasma glucose level on all-cause mortality in older patients with acute myocardial infarction: results from the Beijing Elderly Acute Myocardial Infarction Study (BEAMIS) |
| Q51496269 | Effects of improved metabolic control on platelet reactivity in patients with type 2 diabetes mellitus following coronary angioplasty. |
| Q48140197 | Effects of mealtime insulin aspart and bedtime NPH insulin on postprandial inflammation and endothelial cell function in patients with type 2 diabetes. |
| Q40153092 | Glucose Transporter 3 Potentiates Degranulation and Is Required for Platelet Activation. |
| Q37032717 | Glycemic control in non-diabetic critically ill patients |
| Q36339645 | High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets |
| Q46053500 | How to manage hyperglycemia in an acute coronary syndrome patient |
| Q50117938 | Hyperglycemia is associated with cardiac complications in elderly nondiabetic patients receiving total parenteral nutrition |
| Q33873092 | Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent. |
| Q36720262 | Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction |
| Q54263469 | Impact of perioperative hyperglycemia in patients undergoing microvascular reconstruction. |
| Q92812693 | Influence of Cardiometabolic Risk Factors on Platelet Function |
| Q51371087 | Influence of abnormal fasting plasma glucose on left ventricular function in older patients with acute myocardial infarction. |
| Q37082032 | Insulin therapy for the management of hyperglycemia in hospitalized patients |
| Q35685021 | Intensive control of diabetes in the hospital: why, how, and what is in the future? |
| Q36680678 | Intensive insulin therapy in the intensive cardiac care unit |
| Q43260524 | Laropiprant in combination with extended-release niacin does not alter urine 11-dehydrothromboxane B2, a marker of in vivo platelet function, in healthy, hypercholesterolemic, and diabetic subjects |
| Q42678700 | Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide |
| Q35149077 | Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction |
| Q34994655 | Methylglyoxal induces platelet hyperaggregation and reduces thrombus stability by activating PKC and inhibiting PI3K/Akt pathway |
| Q28196653 | NCX4016: a novel antithrombotic agent |
| Q42451736 | Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus |
| Q46877727 | Oxidant release is dramatically increased by elevated glucose concentrations in neutrophils from pregnant women |
| Q37016837 | Perioperative Blood Glucose Levels <150 mg/dL are Associated With Improved 5-Year Survival in Patients Undergoing On-Pump Cardiac Surgery: A Prospective, Observational Cohort Study |
| Q50179688 | Perioperative Management of Hyperglycemia and Diabetes in Cardiac Surgery Patients |
| Q28219419 | Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin |
| Q28200449 | Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders |
| Q42520665 | Platelet free cytosolic calcium concentration during ageing of type 2 diabetic patients |
| Q37184596 | Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents |
| Q53200400 | Platelet reactivity in type 2 diabetes mellitus: a comparative analysis with survivors of myocardial infarction and the role of glycaemic control. |
| Q35521022 | Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes |
| Q38979950 | Preprocedural Prediction Model for Contrast-Induced Nephropathy Patients |
| Q46675068 | Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance |
| Q86588599 | Relationship between admission blood glucose level and prognosis in elderly patients without previously known diabetes who undergo emergency non-cardiac surgery |
| Q91734042 | Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study |
| Q60947291 | Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications |
| Q64285145 | Streptozotocin-Induced Diabetes Mellitus – a Paradox of High Intrinsic Platelet Reactivity and Low In Vitro Platelet Aggregation |
| Q35950337 | Stress Hyperglycemia During Surgery and Anesthesia: Pathogenesis and Clinical Implications |
| Q49608688 | Stress hyperglycemia in general surgery: Why should we care? |
| Q37782025 | TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus. |
| Q36333927 | The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes |
| Q51111454 | The mean platelet volume is significantly associated with higher glycated hemoglobin in a large population of unselected outpatients. |
| Q54948267 | Update on Glucose Management Among Noncritically Ill Patients Hospitalized on Medical and Surgical Wards. |
Search more.